Salter Malcolm 4
4 · C4 Therapeutics, Inc. · Filed Jun 17, 2021
Insider Transaction Report
Form 4
Salter Malcolm
Director
Transactions
- Award
Stock Option (Right to Buy)
2021-06-15+23,500→ 23,500 totalExercise: $37.66Exp: 2031-06-14→ Common Stock (23,500 underlying)
Footnotes (1)
- [F1]This option shall vest and become exercisable in full upon the earlier to occur of (i) June 15, 2022 and (ii) the next annual meeting of the Issuer's stockholders.